Microbot Medical Statistics
Total Valuation
MBOT has a market cap or net worth of $135.66 million. The enterprise value is $107.16 million.
Important Dates
The next estimated earnings date is Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MBOT has 67.16 million shares outstanding. The number of shares has increased by 92.97% in one year.
| Current Share Class | 67.16M |
| Shares Outstanding | 67.16M |
| Shares Change (YoY) | +92.97% |
| Shares Change (QoQ) | +17.38% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 9.34% |
| Float | 67.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 12.88 |
| PB Ratio | 2.65 |
| P/TBV Ratio | 4.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.06, with a Debt / Equity ratio of 0.00.
| Current Ratio | 12.06 |
| Quick Ratio | 11.98 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -69.80% and return on invested capital (ROIC) is -45.88%.
| Return on Equity (ROE) | -69.80% |
| Return on Assets (ROA) | -41.52% |
| Return on Invested Capital (ROIC) | -45.88% |
| Return on Capital Employed (ROCE) | -44.32% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$635,400 |
| Employee Count | 20 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +118.06% in the last 52 weeks. The beta is 1.18, so MBOT's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | +118.06% |
| 50-Day Moving Average | 3.06 |
| 200-Day Moving Average | 2.50 |
| Relative Strength Index (RSI) | 30.07 |
| Average Volume (20 Days) | 2,580,501 |
Short Selling Information
The latest short interest is 4.23 million, so 6.29% of the outstanding shares have been sold short.
| Short Interest | 4.23M |
| Short Previous Month | 4.54M |
| Short % of Shares Out | 6.29% |
| Short % of Float | 6.29% |
| Short Ratio (days to cover) | 0.96 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -13.47M |
| Pretax Income | -12.71M |
| Net Income | -12.71M |
| EBITDA | -13.40M |
| EBIT | -13.47M |
| Earnings Per Share (EPS) | -$0.50 |
Full Income Statement Balance Sheet
The company has $32.67 million in cash and $149,000 in debt, giving a net cash position of $32.53 million or $0.48 per share.
| Cash & Cash Equivalents | 32.67M |
| Total Debt | 149,000 |
| Net Cash | 32.53M |
| Net Cash Per Share | $0.48 |
| Equity (Book Value) | 30.36M |
| Book Value Per Share | 0.80 |
| Working Capital | 30.16M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$9.90 million and capital expenditures -$29,000, giving a free cash flow of -$9.93 million.
| Operating Cash Flow | -9.90M |
| Capital Expenditures | -29,000 |
| Free Cash Flow | -9.93M |
| FCF Per Share | -$0.15 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MBOT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -92.97% |
| Shareholder Yield | -92.97% |
| Earnings Yield | -9.10% |
| FCF Yield | -7.11% |
Analyst Forecast
The average price target for MBOT is $12.00, which is 494.06% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 494.06% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 5, 2018. It was a reverse split with a ratio of 1:15.
| Last Split Date | Sep 5, 2018 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |